Lovelace Biomedical published a blog post titled 'The goal is not the largest possible dataset. It is the information needed to support the next meaningful decision' that highlights the importance of fast, clean answers in drug development.

Building on a history of pioneering science and technological innovation, Lovelace Biomedical is a contract research organization that helps pharmaceutical and biotechnology companies advance their discoveries—no matter how complex—into clinical testing and beyond. The organization leverages a multidisciplinary toolset to push the limits of preclinical research and fully understand the behavior of its clients’ investigational products. Lovelace Biomedical provides a unique experimental breadth and logistical capacity to solve specialized challenges that other CROs are not equipped to handle, featuring expansive bio-secure facilities and ongoing access to industry-leading scientific experts. The team thrives on developing programs for complex diseases, emerging drug classes and delivery mechanisms, and challenging areas of drug development while delivering the same level of rigor and attention to seemingly straightforward studies that are just as critical to regulatory success.